Bruker (BRKRP) Cash & Current Investments (2016 - 2025)
Bruker's Cash & Current Investments history spans 17 years, with the latest figure at $322.6 million for Q4 2025.
- For Q4 2025, Cash & Current Investments rose 68.9% year-over-year to $322.6 million; the TTM value through Dec 2025 reached $322.6 million, up 68.9%, while the annual FY2025 figure was $322.6 million, 68.9% up from the prior year.
- Cash & Current Investments reached $322.6 million in Q4 2025 per BRKRP's latest filing, roughly flat from $321.4 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $1.2 billion in Q4 2021 to a low of $96.3 million in Q2 2025.
- Average Cash & Current Investments over 5 years is $507.3 million, with a median of $532.2 million recorded in 2023.
- Peak YoY movement for Cash & Current Investments: plummeted 64.89% in 2024, then skyrocketed 76.21% in 2025.
- A 5-year view of Cash & Current Investments shows it stood at $1.2 billion in 2021, then plummeted by 43.12% to $664.5 million in 2022, then fell by 26.34% to $489.5 million in 2023, then plummeted by 60.98% to $191.0 million in 2024, then soared by 68.9% to $322.6 million in 2025.
- Per Business Quant, the three most recent readings for BRKRP's Cash & Current Investments are $322.6 million (Q4 2025), $321.4 million (Q3 2025), and $96.3 million (Q2 2025).